The prevalence of metabolic syndrome increases with serum high sensitivity C-reactive protein concentration in individuals without a history of cardiovascular disease: a report from a large Persian cohort

Annals of Clinical Biochemistry

Volumn 54, Issue 6, 2017, Pages 644-648

  Kazemi Bajestani, Seyyed MR ^a,b   Tayefi, Maryam ^a,c   Ebrahimi, Mahmoud ^a   Heidari Bakavoli, Ali R ^a   Moohebati, Mohsen ^a   Parizadeh, Seyyed MR ^a,c   Esmaeili, Habibollah ^d   Ferns, Gordon AA ^e   Ghayour Mobarhan, Majid ^a,c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF ALBERTA   (Canada)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

Author keywords

Cardiology; clinical studies; nutrition

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; SMOKING HABIT; BLOOD; COMPLICATION; IRAN; METABOLISM; RISK FACTOR;

C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; IRAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 85017449216     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563216676842     Document Type: Article

References (26)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415–1428.
2. Beltran-Sanchez H, Harhay MO, Harhay MM, Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999–2010. J Am Coll Cardiol 2013; 62: 697–703.
3. Azimi-Nezhad M, Herbeth B, Siest G, High prevalence of metabolic syndrome in Iran in comparison with France: what are the components that explain this? Metab Syndr Relat Disord 2012; 10: 181–188.
4. Ebrahimi M, Kazemi-Bajestani SM, Ghayour-Mobarhan M, Metabolic syndrome may not be a good predictor of coronary artery disease in the Iranian population: population-specific definitions are required. Sci World J 2009; 9: 86–96.
5. Nezhad MA, Ghayour-Mobarhan M, Parizadeh SM, Metabolic syndrome: its prevalence and relationship to socio-economic parameters in an Iranian population. Nutr Metab Cardiovasc Dis 2008; 18: e11–e12.
6. Berk BC, Weintraub WS, Alexander RW. Elevation of C-reactive protein in “active” coronary artery disease. Am J Cardiol 1990; 65: 168–172.
7. Ford ES, Giles WH. Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction: findings from National Health and Nutrition Examination Survey III. J Clin Epidemiol 2000; 53: 95–102.
8. Kazemi-Bajestani SM, Azarpazhooh MR, Ebrahimi M, Serum high sensitivity CRP concentrations predict the presence of carotid artery plaque in individuals without a history of cardiovascular events. Nutr Metab Cardiovasc Dis 2015; 25: 434–435.
9. Kazemi-Bajestani SM, Ghayour-Mobarhan M, Ebrahimi M, C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease. Clin Lab 2007; 53: 49–56.
10. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103: 1813–1818.
11. Linnemann B, Voigt W, Nobel W, C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome. Exp Clin Endocrinol Diabetes 2006; 114: 127–134.
12. Ridker PM. C-reactive protein, inflammation, and cardiovascular disease: clinical update. Tex Heart Inst J 2005; 32: 384–386.
13. Ridker PM, Wilson PW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004; 109: 2818–2825.
14. Huffman FG, Gomez GP, Zarini GG. Metabolic syndrome and high-sensitivity C-reactive protein in Cubans. Ethn Dis 2009; 19: 115–120.
15. Kang ES, Kim HJ, Ahn CW, Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes. Diabetes Res Clin Pract 2005; 69: 151–159.
16. Voils SA, Cooper-DeHoff RM. Association between high sensitivity C-reactive protein and metabolic syndrome in subjects completing the National Health and Nutrition Examination Survey (NHANES) 2009–10. Diabetes Metab Syndr 2014; 8: 88–90.
17. Devaraj S, Singh U, Jialal I. Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol 2009; 20: 182–189.
18. Roberts WL. CDC, AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: application to Clinical and Public Health Practice: laboratory tests available to assess inflammation – performance and standardization: a background paper. Circulation 2004; 110: e572–e576.
19. Ridker PM. Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation 2003; 108: e81–e85.
20. Xue H, Wang J, Hou J, Ideal cardiovascular health behaviors and factors and high sensitivity C-reactive protein: the Kailuan cross-sectional study in Chinese. Clin Chem Lab Med 2014; 52: 1379–1386.
21. Hiramoto JS, Katz R, Weisman S, Gender-specific risk factors for peripheral artery disease in a voluntary screening population. J Am Heart Assoc 2014; 3: e000651–e000651.
22. Khadir A, Tiss A, Kavalakatt S, Gender-specific association of oxidative stress and inflammation with cardiovascular risk factors in Arab population. Mediators Inflamm 2015; 2015: 512603–512603.
23. Qasim AN, Budharaju V, Mehta NN, Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetes. Clin Endocrinol (Oxf) 2011; 74: 44–50.
24. Hung MY, Hsu KH, Hu WS, Gender-specific prognosis and risk impact of C-reactive protein, hemoglobin and platelet in the development of coronary spasm. Int J Med Sci 2013; 10: 255–264.
25. Sauriasari R, Sakano N, Wang DH, C-reactive protein is associated with cigarette smoking-induced hyperfiltration and proteinuria in an apparently healthy population. Hypertens Res 2010; 33: 1129–1136.
26. Tonstad S, Cowan JL. C-reactive protein as a predictor of disease in smokers and former smokers: a review. Int J Clin Pract 2009; 63: 1634–1641.